Common genetic polymorphisms in the 5′-flanking region of the SULT1A1 gene: Haplotypes and their association with platelet enzymatic activity

Pharmacogenetics and Genomics

Volumn 15, Issue 7, 2005, Pages 465-473

  Ning, Baitang ^a   Nowell, Susan ^a,b   Sweeney, Carol ^c   Ambrosone, Christine B ^b   Williams, Suzanne ^d   Miao, Xiaoping ^e   Liang, Gang ^e   Lin, Dongxin ^e   Stone, Angie ^a   Ratnasinghe, D Luke ^a   Manjanatha, Mugimane ^a   Lang, Nicholas P ^d,f   Kadlubar, Fred F ^a  

^a National Center for Toxicological Research   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^e PEKING UNION MEDICAL COLLEGE   (China)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Activity; Genotype; Haplotype; Sulphotransferase

Indexed keywords

GENE PRODUCT; PHENOL DERIVATIVE; SULFOTRANSFERASE; SULFOTRANSFERASE 1A1; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BIOTRANSFORMATION; CAUCASIAN; CHINESE; CONTROLLED STUDY; CORRELATION ANALYSIS; DETOXIFICATION; DNA FLANKING REGION; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; SULT1A1 GENE; THROMBOCYTE;

EID: 22544443376     PISSN: 17446872     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fpc.0000166823.74378.79     Document Type: Article

References (40)

1. Jakoby WB, Ziegler DM. The enzymes of detoxication. J Biol Chem 1990; 265:20715-20718.
2. Wakabayashi K, Nagao M, Esumi H, Sugimura T. Food-derived mutagens and carcinogens. Cancer Res 1992; 52:20923-20983.
3. Glatt H, Engelke CE, Pabel U, Teubner W, Jones AL, Coughtrie MW, et al. Sulfotransferases: genetics and role in toxicology. Toxicol Lett 2000; 112-113:341-348.
4. Renskers KJ, Feor KD, Roth JA. Sulfation of dopamine and other biogenic amines by human brain phenol sulfotransferase. J Neurochem 1980; 34:1362-1368.
5. Reiter C, Mwaluko G, Dunnette J, Van Loon J, Weinshilboum R. Thermolabile and thermostable human platelet phenol sulfotransferase. Substrate specificity and physical separation. Naunyn Schmiedeberg's Arch Pharmacol 1983; 324:140-147.
6. Young WF Jr, Gorman CA, Weinshilboum RM. Triiodothyronine: a substrate for the thermostable and thermolabile forms of human phenol sulfotransferase. Endocrinology 1988; 122:1816-1824.
7. Falany CN, Zhuang W, Falany JL. Characterization of expressed human phenol-sulfating phenol sulfotransferase: effect of mutating cys70 on activity and thermostability. Chem Biol Interact 1994; 92:57-66.
8. Chou HC, Lang NP, Kadlubar FF. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Cancer Res 1995; 55:525-529.
9. Kester MH, Kaptein E, Roest TJ, van Dijk CH, Tibboel D, Meinl W, et al. Characterization of human iodothyronine sulfotransferases. J Clin Endocrinol Metab 1999; 84:1357-1364.
10. Spink BC, Katz BH, Hussain MM, Pang S, Connor SP, Aldous KM, et al. SULT1A1 catalyzes 2-methoxyestradiol sulfonation in MCF-7 breast cancer cells. Carcinogenesis 2000; 21:1947-1957.
11. Suiko M, Sakakibara Y, Liu MC. Sulfation of environmental estrogen-like chemicals by human cytosolic sulfotransferases. Biochem Biophys Res Commun 2000; 267:80-84.
12. Harris RM, Waring RH, Kirk CJ, Hughes PJ. Sulfation of 'estrogenic' alkylphenols and 17beta-estradiol by human platelet phenol sulfotransferases. J Biol Chem 2000; 275:159-166.
13. Glatt H, Boeing H, Engelke CE, Ma L, Kuhlow A, Pabel U, et al. Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. Mutat Res 2001; 482:27-40.
14. Sundaram RS, Van Loon JA, Tucker R, Weinshilboum RM. Sulfation pharmacogenetics: correlation of human platelet and small intestinal phenol sulfotransferase. Clin Pharmacol Ther 1989; 46:501-509.
15. Young WF Jr, Laws ER Jr, Sharbrough FW, Weinshilboum RM. Human phenol sulfotransferase: correlation of brain and platelet activities. J Neurochem 1985; 44:1131-1137.
16. Marazziti D, Palego L, Mazzanti C, Silvestri S, Cassano GB. Human platelet sulfotransferase shows seasonal rhythms. Chronobiol Int 1995; 12: 100-105.
17. Marazziti D, Palego L, Rossi A, Cassano GB. Gender-related seasonality of human platelet phenolsulfotransferase activity. Neuropsychobiology 1998; 38:1-5.
18. Nowell S, Ambrosone CB, Ozawa S, MacLeod SL, Mrackova G, Williams S, et al. Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol. Pharmacogenetics 2000; 10:789-797.
19. Khetawat G, Faraday N, Nealen ML, Vijayan KV, Bolton E, Noga SJ, et al. Human megakaryocytes and platelets contain the estrogen receptor beta and androgen receptor (AR): testosterone regulates AR expression. Blood 2000; 95:2289-2296.
20. Tarantino MD, Kunicki TJ, Nugent DJ. The estrogen receptor is present in human megakaryocytes. Ann NY Acad Sci 1994; 714:293-296.
21. Brittelli A, De Santi C, Raunio H, Pelkonen O, Rossi G, Pacifici GM. Interethnic and interindividual variabilities of platelet sulfotransferases activity in Italians and Finns. Eur J Clin Pharmacol 1999; 55:691-695.
22. Anderson RJ, Jackson BL, Liebentritt DK. Human platelet thermostable phenol sulfotransferase from blacks and whites: biochemical properties and variations in thermal stability. J Lab Clin Med 1988; 112:773-783.
23. Raftogianis RB, Wood TC, Otterness DM, Van Loon JA, Weinshilboum RM. Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 1997; 239:298-304.
24. Ozawa S, Tang YM, Yamazoe Y, Kato R, Lang NP, Kadlubar FF. Genetic polymorphisms in human liver phenol sulfotransferases involved in the bioactivation of N-hydroxy derivatives of carcinogenic arylamines and heterocyclic amines. Chem Biol Interact 1998; 109:237-248.
25. Raftogianis RB, Wood TC, Weinshilboum RM. Human phenol sulfotransferases SULT1A2 and SULT1A1: genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochem Pharmacol 1999; 58:605-616.
26. Carlini EJ, Raftogianis RB, Wood TC, Jin F, Zheng W, Rebbeck TR, et al. Sulfation pharmacogenetics: SULT1A1 and SULT1A2 allele frequencies in Caucasian, Chinese and African-American subjects. Pharmacogenetics 2001; 11:57-68.
27. Rebbeck TR, Ambrosone CB, Bell DA, Chanock SJ, Hayes RB, Kadlubar FF, et al. SNPs, Haplotypes, and Cancer: Applications in Molecular Epidemiology. Cancer Epidemiol Biomarkers Prev 2004; 13:681-687.
28. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994; 22:4673-4680.
29. Nowell S, Sweeney C, Hammons G, Kadlubar FF, Lang NP. CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 2002; 11:377-383.
30. Nowell S, Ratnasinghe DL, Ambrosone CB, Williams S, Teague-Ross T, Trimble L, et al. Association of SULT1A1 phenotype and genotype with prostate cancer risk in African-Americans and Caucasians. Cancer Epidemiol Biomarkers Prev 2004; 13:270-276.
31. Mulder GJ, Hinson JA, Gillette JR. Generation of reactive metabolites of N-hydroxy-phenacetin by glucoronidation and sulfation. Biochem Pharmacol 1977; 26:189-196.
32. Frame LT, Ozawa S, Nowell SA, Chou HC, DeLongchamp RR, Doerge DR, et al. A simple colorimetric assay for phenotyping the major human thermostable phenol sulfotransferase (SULT1A1) using platelet cytosols. Drug Metab Dispos 2000; 28:1063-1068.
33. Mulder GJ, Scholtens E. Phenol sulphotransferase and uridine diphosphate glucuronyltransferase from rat liver in vivo and vitro. 2,6-Dichloro-4- nitrophenol as selective inhibitor of sulphation. Biochem J 1977; 165: 553-559.
34. Grabe N. AliBaba2: context specific identification of transcription factor binding sites. In Silico Biol 2002; 2:S1-S15.
35. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 1995; 29:311-322.
36. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-989.
37. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73:1162-1169.
38. Hempel N, Wang H, LeCluyse EL, Negishi M, McManus ME. The human sulfotransferase SULT1A1 gene is regulated in a synergistic manner by Sp1 and GA binding protein. Mol Pharmacol 2004; 66:1690-1701.
39. Smale ST, Schmidt MC, Berk AJ, Baltimore D. Transcriptional activation by Sp1 as directed through TATA or initiator: specific requirement for mammalian transcription factor IID. Proc Natl Acad Sci USA 1990; 87:4509-4513.
40. Blake MC, Jambou RC, Swick AG, Kahn JW, Azizkhan JC. Transcriptional initiation is controlled by upstream GC-box interactions in a TATAA-less promoter. Mol Cell Biol 1990; 10:6632-6641.